Hearings on National Defense Authorization Act for Fiscal Year 1997--H.R. 3230 and Oversight of Previously Authorized Programs Before the Committee on National Security, House of Representatives, One Hundred Fourth Congress, Second Session: Military Research and Development Subcommittee Hearings on Title II--Research, Development, Test, and Evaluation : Hearings Held March 5 and 12, 1996U.S. Government Printing Office, 1997 - 289 pages |
Other editions - View all
Common terms and phrases
acquisition activities agencies Air Force analysis Applied Physics Laboratory ARPA assessment attack biological agents biological defense biological warfare biological weapons budget capabilities CB DEFENSE ceiling Chairman Chemical Agent chemical and biological CHEMICAL/BIOLOGICAL commanders committee Congress contract contractors COORDINATION core Corporation decontamination DEFENSE PROGRAM Department of Defense detection detector Development Centers DOD's efforts emergency equipment Federal Response Plan Federally Funded Research FEMA FFRDCs and UARCs fiscal industry Institute integration issues JOINT SERVICE Kaminski Lincoln Laboratory mask mass destruction military MILSTAR missile mission national security Navy NBC defense operations organizations oversight percent personnel Pete Aldridge problems PROCIV protective relationship requirements Research and Development RICIN Sarin Secretary of Defense software engineering Software Engineering Institute space systems sponsors staff statement strategy subcommittee systems engineering technical terrorism terrorist terrorist incident Thank threat U.S. forces vaccines warfare weapons of mass WELDON
Popular passages
Page 218 - I am from the Government and I am here to help you, but I really am.
Page 232 - THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, THE DEPARTMENT OF DEFENSE, AND THE US POSTAL SERVICE.
Page 160 - MR. CHAIRMAN AND MEMBERS OF THE COMMITTEE, THANK YOU FOR THIS OPPORTUNITY TO DISCUSS THE DEPARTMENT OF DEFENSE CHEMICAL AND BIOLOGICAL DEFENSE PROGRAM.
Page 163 - DOD center of expertise for nuclear and special weapons effects, and operates under the authority, direction, and control of the Assistant to the Secretary of Defense for Nuclear and Chemical and Biological Defense Programs (ATSD(NCB)).
Page 171 - Pound for pound biologicals are orders of magnitude more deadly than chemicals. Critical elements of medical biological defense include the ability to rapidly identify an agent and the ability to provide prophylactic and/or therapeutic protection from the agent. Often, the most effective countermeasure is predeployment active immunization. The current program includes the following research areas for the development of medical biological agent countermeasures: Characterize molecular biology and physiology...
Page 171 - IN ACCOMPLISHING THE GOALS OF THE MEDICAL BIOLOGICAL DEFENSE RESEARCH PROGRAM, EFFORTS ARE FOCUSED ON THREE OBJECTIVES : • PREVENT CASUALTIES WITH MEDICAL COUNTERMEASURES (THROUGH THE USE OF VACCINES, DRUGS, AND OTHER MEDICAL TREATMENTS...
Page 20 - Mr. Chairman, members of the subcommittee, and staff, thank you for the opportunity to appear before you today to discuss the...
Page 163 - ATSD (NCB) is therefore responsible for the oversight, coordination ana integration of all CB defense medical and non-medical efforts; and provides the overall guidance for planning, programming, budgeting, and executing the CBD programs. The Secretary of the Army as the executive agent is responsible for ensuring the coordination and integration of the services' CBD requirements and RDA programs.
Page 113 - There was the request that the secretaries of the military departments and the heads of other DOD components review work performed, and finally, the fourth paragraph talked about DDR&E participating in the DOD FFRDC sponsors
Page 123 - OFFICE OF FEDERAL PROCUREMENT POLICY ACT AN ACT To establish an Office of Federal Procurement Policy within the Office of Management and Budget, and for other purposes.